These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 6757311)

  • 21. Glucocorticoid therapy in the fetus and newborn--Introduction.
    Dammann O; Matthews SG
    Semin Neonatol; 2001 Aug; 6(4):283-4. PubMed ID: 11972429
    [No Abstract]   [Full Text] [Related]  

  • 22. [Prenatal prevention of the respiratory syndrome. I. Current status of knowledge].
    Meriggi E; Parenti MR
    Minerva Ginecol; 1980 Mar; 32(3):175-86. PubMed ID: 6103524
    [No Abstract]   [Full Text] [Related]  

  • 23. [Factors increasing susceptibility to neonatal hyaline membrane syndrome and its prevention. I. Deficiency of surfactant and glucocorticoid treatment].
    Uszyńska-Folejewska R; Uszyński M
    Pediatr Pol; 1977 Dec; 52(12):1413-7. PubMed ID: 343058
    [No Abstract]   [Full Text] [Related]  

  • 24. New frontiers in prenatal prevention of respiratory distress syndrome.
    Cosmi EV
    J Perinat Med; 1991; 19 Suppl 1():170-5. PubMed ID: 1779354
    [No Abstract]   [Full Text] [Related]  

  • 25. [Critical study of the use of glucocorticoids in the prevention of hyaline membrane disease].
    Leroy JL
    J Gynecol Obstet Biol Reprod (Paris); 1982; 11(1):152-7. PubMed ID: 6896522
    [No Abstract]   [Full Text] [Related]  

  • 26. [Medical prevention of respiratory distress syndrome].
    Lorenz U; Jürgens S; Ragosch V; Kipper-Kreissl B; Weitzel H
    Gynakologe; 1991 Aug; 24(4):223-7. PubMed ID: 1937164
    [No Abstract]   [Full Text] [Related]  

  • 27. [Dilemmas about the antenatal use of corticosteroids for prevention of neonatal morbidity and mortality].
    Grgić O; Matijević R
    Acta Med Croatica; 2005; 59(2):129-35. PubMed ID: 15909887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevention of pediatric respiratory distress syndrome with special reference to glucocorticoids].
    Gerner R
    Med Klin (Munich); 1990 Mar; 85(3):151-5. PubMed ID: 2186262
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prevention of idiopathic respiratory distress (hyaline membrane disease)].
    Amiel-Tison C; Tchobroutsky C
    Rev Prat; 1981 Jan; 31(5):345-8, 351. PubMed ID: 7466260
    [No Abstract]   [Full Text] [Related]  

  • 30. [Corticosteroid for fetal lung maturation: indication and treatment protocols].
    Senat MV
    J Gynecol Obstet Biol Reprod (Paris); 2002 Nov; 31(7 Suppl):5S105-13. PubMed ID: 12454632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of exogenous maternal glucocorticoids to prevent neonatal respiratory distress syndrome (RDS)--the state of the facts.
    Zachman RD
    Wis Med J; 1976 Sep; 75(9):S91-2. PubMed ID: 969558
    [No Abstract]   [Full Text] [Related]  

  • 32. [The effect of glucocorticoids and other prenatal factors on fetal lung maturity].
    Melková J; Pokorný A; Broscheová M; Srp B; Hájek Z
    Cesk Pediatr; 1986 Nov; 41(11):658-63. PubMed ID: 3791473
    [No Abstract]   [Full Text] [Related]  

  • 33. [Induction of fetal lung maturation in the prevention of hyaline membrane disease: the connection with neonatal sepsis].
    Driul L; Furlan R; Macagno F; Pezzani I; Plaino L; Ianni A; Casarsa S; Zavarise D; Marchesoni D
    Minerva Ginecol; 2003 Feb; 55(1):37-42. PubMed ID: 12598841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Stimulation of fetal lung development].
    Leszczyńska-Grzelak B; Oleszczuk J
    Wiad Lek; 1995; 48(1-12):227-9. PubMed ID: 9638246
    [No Abstract]   [Full Text] [Related]  

  • 35. Undesired effects of steroids during pregnancy.
    Mariotti V; Marconi AM; Pardi G
    J Matern Fetal Neonatal Med; 2004 Nov; 16 Suppl 2():5-7. PubMed ID: 15590425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ACOG Practice Bulletin No. 97: Fetal lung maturity.
    American College of Obstetricians and Gynecologists
    Obstet Gynecol; 2008 Sep; 112(3):717-26. PubMed ID: 18757686
    [No Abstract]   [Full Text] [Related]  

  • 37. [Amniotic fluid testing - importance to prophylaxis against idiopathic respiratory distress syndrome (author's transl)].
    Prievara F; Vágvölgyi E; Bánk J; Domány S
    Zentralbl Gynakol; 1981; 103(23):1463-6. PubMed ID: 7331592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Animal experiment and clinical studies of the significance of carnitine for energy metabolism in pregnant patients and the fetus during the pre- and perinatal period].
    Lohninger A; Laschan C; Auer B; Linhart L; Salzer H
    Wien Klin Wochenschr; 1996; 108(2):33-9. PubMed ID: 8835430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Perinatal corticotherapy: updates].
    Hamon I; Hascoet JM
    J Gynecol Obstet Biol Reprod (Paris); 2001 Oct; 30(6 Suppl):S50-3. PubMed ID: 11883016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The relation between the gastric aspirate foam test and pulmonary maturity in the newborn infant].
    colombo ML; Dogliani P; Raggi M
    Minerva Pediatr; 1980 Jan; 32(1):1-6. PubMed ID: 6894779
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.